BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38535451)

  • 1. Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors.
    Li T; Tae HS; Liang J; Zhang Z; Li X; Jiang T; Adams DJ; Yu R
    Mar Drugs; 2024 Feb; 22(3):. PubMed ID: 38535451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Action and Structure-Activity Relationship of α-Conotoxin Mr1.1 at the Human α9α10 Nicotinic Acetylcholine Receptor.
    Liang J; Tae HS; Zhao Z; Li X; Zhang J; Chen S; Jiang T; Adams DJ; Yu R
    J Med Chem; 2022 Dec; 65(24):16204-16217. PubMed ID: 36137181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
    Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
    ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
    Daly NL; Callaghan B; Clark RJ; Nevin ST; Adams DJ; Craik DJ
    J Biol Chem; 2011 Mar; 286(12):10233-7. PubMed ID: 21252227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
    J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.
    Hone AJ; Ruiz M; Scadden M; Christensen S; Gajewiak J; Azam L; McIntosh JM
    J Biol Chem; 2013 Aug; 288(35):25428-25439. PubMed ID: 23846688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
    Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
    J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
    Mohammadi SA; Christie MJ
    Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
    Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
    J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor.
    Huang Q; Chu X; Zhang H; Yu S; Zhang L; Zhang X; Yu R; Guo C; Dai Q
    ACS Chem Biol; 2022 Sep; 17(9):2483-2494. PubMed ID: 36048451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
    Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.
    Hone AJ; Fisher F; Christensen S; Gajewiak J; Larkin D; Whiteaker P; McIntosh JM
    J Med Chem; 2019 Jul; 62(13):6262-6275. PubMed ID: 31194549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
    Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
    J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
    Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
    Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
    Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
    J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
    van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
    Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
    Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
    Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
    Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
    Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
    Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
    J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.